Boston University scientists developed an AI model that predicts Alzheimer's-related protein levels using brain imaging and clinical data.
Key Details
- 1AI tool predicts presence of amyloid beta and tau proteins linked to Alzheimer's disease.
- 2Model incorporates brain scans, cognitive scores, genetics, and health history from 12,185 participants across seven cohorts.
- 3Tool provides location-specific brain information, unlike most blood tests.
- 4Successfully validated on a separate international cohort, showing robust predictive performance.
- 5Aims to enable earlier, cheaper, and more accessible Alzheimer's detection and staging.
- 6Published in Nature Communications on August 11, 2025.
Why It Matters
Accurate, cost-effective early detection of Alzheimer's using non-invasive imaging and AI could transform patient care and expedite selection for clinical trials. This approach highlights the expanding role of imaging AI in neurological disease diagnosis and management.
Source
EurekAlert
Related News
•EurekAlert
Sybil AI Model Accurately Predicts Lung Cancer Risk in Diverse Urban Populations
A new study validates the Sybil AI model for predicting lung cancer risk using low-dose CT in a predominantly Black cohort at an urban safety-net hospital.
•EurekAlert
AI and Imaging Reveal Atomic Order in 2D Nanomaterials
A multi-university team has uncovered how atomic order and disorder in 2D MXene nanomaterials can be predicted and tailored using AI, enabled by advanced imaging analysis.
•EurekAlert
DreamConnect AI Translates and Edits fMRI Brain Activity into Images
Researchers unveil DreamConnect, an AI system that reconstructs and edits visual imagery from fMRI brain data with language prompts.